Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 119, Issue 3, Pages 2653-2665
Publisher
Wiley
Online
2017-10-23
DOI
10.1002/jcb.26433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sphingosine-1-phosphate signaling: unraveling its role as a drug target against infectious diseases
- (2016) Mohd Arish et al. DRUG DISCOVERY TODAY
- Docking and molecular dynamics simulation study of EGFR1 with EGF-like peptides to understand molecular interactions
- (2016) D. Raja Sudhakar et al. Molecular BioSystems
- UDP-galactopyranose mutase, a potential drug target against human pathogenic nematodeBrugia malayi
- (2016) Sweta Misra et al. Pathogens and Disease
- Orchestration of membrane receptor signaling by membrane lipids
- (2015) Mohd Arish et al. BIOCHIMIE
- Deciphering key features in protein structures with the new ENDscript server
- (2014) Xavier Robert et al. NUCLEIC ACIDS RESEARCH
- Insight into the Effect of Inhibitor Resistant S130G Mutant on Physico-Chemical Properties of SHV Type Beta-Lactamase: A Molecular Dynamics Study
- (2014) Mohd Hassan Baig et al. PLoS One
- Leishmanicidal activities of Artemisia annua leaf essential oil against Visceral Leishmaniasis
- (2014) Mohammad Islamuddin et al. Frontiers in Microbiology
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
- (2013) Sander Pronk et al. BIOINFORMATICS
- Targeting UDP-Galactopyranose Mutases from Eukaryotic Human Pathogens
- (2013) Karina Kizjakina et al. CURRENT PHARMACEUTICAL DESIGN
- Crystal Structures of Trypanosoma cruzi UDP-Galactopyranose Mutase Implicate Flexibility of the Histidine Loop in Enzyme Activation
- (2012) Richa Dhatwalia et al. BIOCHEMISTRY
- Leishmania-Induced Biphasic Ceramide Generation in Macrophages Is Crucial for Uptake and Survival of the Parasite
- (2012) Saikat Majumder et al. JOURNAL OF INFECTIOUS DISEASES
- Chemical Mechanism of UDP-Galactopyranose Mutase from Trypanosoma cruzi: A Potential Drug Target against Chagas' Disease
- (2012) Michelle Oppenheimer et al. PLoS One
- Virtual Screening, Identification and In Vitro Testing of Novel Inhibitors of O-Acetyl-L-Serine Sulfhydrylase of Entamoeba histolytica
- (2012) Isha Nagpal et al. PLoS One
- Computer-aided drug design platform using PyMOL
- (2010) Markus A. Lill et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Chemoenzymatic Synthesis, Inhibition Studies, and X-ray Crystallographic Analysis of the Phosphono Analog of UDP-Galp as an Inhibitor and Mechanistic Probe for UDP-Galactopyranose Mutase
- (2010) Sarathy Karunan Partha et al. JOURNAL OF MOLECULAR BIOLOGY
- An Improved United Atom Force Field for Simulation of Mixed Lipid Bilayers
- (2009) See-Wing Chiu et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function
- (2009) Abdur Rub et al. NATURE IMMUNOLOGY
- Contribution of Galactofuranose to the Virulence of the Opportunistic PathogenAspergillus fumigatus
- (2008) Philipp S. Schmalhorst et al. EUKARYOTIC CELL
- A Novel Screening Method for Cell Wall Mutants in Aspergillus niger Identifies UDP-Galactopyranose Mutase as an Important Protein in Fungal Cell Wall Biosynthesis
- (2008) R. A. Damveld et al. GENETICS
- Inhibitors of UDP-Galactopyranose Mutase Thwart Mycobacterial Growth
- (2008) Emily C. Dykhuizen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- PDBsum new things
- (2008) R. A. Laskowski NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started